Treatment of Hypertension in the Elderly

Overview

Journal Drugs

Specialty Pharmacology

Date 1993 Jan 1

PMID 7512477

Citations 4

Authors

H Holzgreve

M Middeke

Affiliations

Soon will be listed here.

Abstract

Since 1967, results from well controlled long term studies have provided convincing evidence of the benefit of antihypertensive therapy in middle-aged patients. However, many physicians have hesitated to apply these findings to patients over 60 years of age. Recently, the results of several prospective randomised long term trials investigating the treatment of hypertension in elderly patients have been published. An analysis of the results of 5 major trials shows that antihypertensive treatment reduces overall mortality by 20%, cardiovascular mortality by 33%, the incidence of fatal and nonfatal cerebrovascular events by 40%, and complications as a result of coronary heart disease (i.e. fatal and nonfatal myocardial infarction and sudden cardiac death) by 15%. On the basis of trials undertaken in elderly patients with either high systolic and diastolic blood pressure or isolated systolic hypertension, antihypertensive therapy was more beneficial, in absolute terms, in elderly patients than in middle-aged patients with mild hypertension. Treatment was withdrawn as a result of adverse effects in about 2% of middle-aged and elderly hypertensive patients per year. Therefore, it is clear that elderly hypertensive patients should be treated.

Citing Articles

[Antihypertensive therapy in the elderly].

Schrader J, Schrader B Herz. 2017; 43(3):197-206.

PMID: 29188356 DOI: 10.1007/s00059-017-4642-6.

Hypertension guidelines and their effects on the health system.

Frank W, Konta B GMS Health Technol Assess. 2011; 1:Doc11.

PMID: 21289932 PMC: 3011314.

Antihypertensive treatment in elderly patients aged 75 years or over: a 24-week study of the tolerability of candesartan cilexetil in relation to hydrochlorothiazide.

Neldam S, Forsen B Drugs Aging. 2001; 18(3):225-32.

PMID: 11302289 DOI: 10.2165/00002512-200118030-00007.

Drug therapy in haemodialysis patients. Special considerations in the elderly.

St Peter W, Clark J, Levos O Drugs Aging. 1998; 12(6):441-59.

PMID: 9638393 DOI: 10.2165/00002512-199812060-00003.

References

. Effects of treatment on morbidity in hypertension. 3. Influence of age, diastolic pressure, and prior cardiovascular disease; further analysis of side effects. Circulation. 1972; 45(5):991-1004. DOI: 10.1161/01.cir.45.5.991. View

. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group. JAMA. 1991; 265(24):3255-64. View

. Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressures averaging 115 through 129 mm Hg. JAMA. 1967; 202(11):1028-34. View

Helgeland A . Treatment of mild hypertension: a five year controlled drug trial. The Oslo study. Am J Med. 1980; 69(5):725-32. DOI: 10.1016/0002-9343(80)90438-6. View

Thijs L, Fagard R, Lijnen P, Staessen J, Van Hoof R, Amery A . A meta-analysis of outcome trials in elderly hypertensives. J Hypertens. 1992; 10(10):1103-9. DOI: 10.1097/00004872-199210000-00001. View

. Effects of treatment on morbidity in hypertension. II. Results in patients with diastolic blood pressure averaging 90 through 114 mm Hg. JAMA. 1970; 213(7):1143-52. View

. Five-year findings of the hypertension detection and follow-up program. I. Reduction in mortality of persons with high blood pressure, including mild hypertension. Hypertension Detection and Follow-up Program Cooperative Group. JAMA. 1979; 242(23):2562-71. View

. MRC trial of treatment of mild hypertension: principal results. Medical Research Council Working Party. Br Med J (Clin Res Ed). 1985; 291(6488):97-104. PMC: 1416260. DOI: 10.1136/bmj.291.6488.97. View

Echt D, Liebson P, Mitchell L, Peters R, BARKER A, Arensberg D . Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial. N Engl J Med. 1991; 324(12):781-8. DOI: 10.1056/NEJM199103213241201. View

10.

Coope J, Warrender T . Randomised trial of treatment of hypertension in elderly patients in primary care. Br Med J (Clin Res Ed). 1986; 293(6555):1145-51. PMC: 1341855. DOI: 10.1136/bmj.293.6555.1145. View

11.

. Five-year findings of the hypertension detection and follow-up program. II. Mortality by race-sex and age. Hypertension Detection and Follow-up Program Cooperative Group. JAMA. 1979; 242(23):2572-7. DOI: 10.1001/jama.1979.03300230028022. View

12.

. Medical Research Council trial of treatment of hypertension in older adults: principal results. MRC Working Party. BMJ. 1992; 304(6824):405-12. PMC: 1995577. DOI: 10.1136/bmj.304.6824.405. View

13.

. The Australian therapeutic trial in mild hypertension. Report by the Management Committee. Lancet. 1980; 1(8181):1261-7. View

14.

Amery A, Birkenhager W, Brixko P, Bulpitt C, Clement D, Deruyttere M . Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial. Lancet. 1985; 1(8442):1349-54. DOI: 10.1016/s0140-6736(85)91783-0. View

15.

Kuramoto K, Matsushita S, Kuwajima I, Murakami M . Prospective study on the treatment of mild hypertension in the aged. Jpn Heart J. 1981; 22(1):75-85. DOI: 10.1536/ihj.22.75. View

16.

Dahlof B, Lindholm L, Hansson L, SCHERSTEN B, Ekbom T, Wester P . Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension). Lancet. 1991; 338(8778):1281-5. DOI: 10.1016/0140-6736(91)92589-t. View

17.

. Treatment of mild hypertension in the elderly. A study initiated and administered by the National Heart Foundation of Australia. Med J Aust. 1981; 2(8):398-402. View

18.

. Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction. N Engl J Med. 1992; 327(4):227-33. DOI: 10.1056/NEJM199207233270403. View